NDC codes

FDA NDC Directory
Product NDC (as listed)72664-211Labeler and product segments. Claims need a package NDC.
Product NDC at billing width72664-0211Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
72664-211-0172664021101100 TABLET in 1 BOTTLE, PLASTIC (72664-211-01)Marketed from Jun 30, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Nadolol
Generic name (nonproprietary)
nadolol
Active ingredients
Nadolol — 20 mg/1
Dosage form
Tablet
Route
Oral
Labeler
VGYAAN Pharmaceuticals LLCNDC labeler code 72664
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 212856
Marketing start
Listing expires
Other FDA classes
Adrenergic beta-Antagonists (Mechanism)
Identifiers
Product ID 72664-211_05f81151-3c12-9235-e063-6294a90af890SPL ID 05f81151-3c12-9235-e063-6294a90af890SPL set ID 85b4b931-51c4-4326-88ea-708dde8323d4RxCUI 198006, 198007, 198008UNII FEN504330V
Pharmacologic class
beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472664021101 followed by a unit qualifier and the quantity

Package 72664-0211-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Angina Pectoris Nadolol is indicated for the long-term management of patients with angina pectoris Hypertension Nadolol tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with nadolol tablets, USP. Control of high blood pressure should be part of comprehensive cardiov…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72664-211

What is NDC 72664-211?
72664-211 is the product NDC for Nadolol, Nadolol 20 mg/1 tablet, listed with the FDA by VGYAAN Pharmaceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Nadolol.
What is the active ingredient?
Nadolol.
Who is the labeler?
VGYAAN Pharmaceuticals LLC, NDC labeler code 72664. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Nadolol?
52 other product NDCs are listed under this name. See all Nadolol NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Nadolol NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
NadololNadolol 40 mg/1TabletOralREMEDYREPACK INC.70518-466270518-4662-00
NadololNadolol 80 mg/1TabletOralBluePoint Laboratories68001-69268001-0692-00
NadololNadolol 20 mg/1TabletOralBluePoint Laboratories68001-69068001-0690-00
NadololNadolol 40 mg/1TabletOralBluePoint Laboratories68001-69168001-0691-00
NadololNadolol 20 mg/1TabletOralAmerican Health Packaging60687-88760687-0887-21
NadololNadolol 40 mg/1TabletOralAmerican Health Packaging60687-89860687-0898-21
NadololNadolol 20 mg/1TabletOralBluePoint Laboratories68001-63068001-0630-00
NadololNadolol 40 mg/1TabletOralBluePoint Laboratories68001-63168001-0631-00
NadololNadolol 80 mg/1TabletOralBluePoint Laboratories68001-63268001-0632-00
NadololNadolol 20 mg/1TabletOralAlembic Pharmaceuticals Limited46708-40246708-0402-3046708-0402-3146708-0402-91

All 53 Nadolol NDCs

Other NDCs under ANDA 212856

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212856
ProductStrengthForm · routeLabelerProduct NDC
NadololNadolol 40 mg/1TabletOralVGYAAN Pharmaceuticals LLC72664-212
NadololNadolol 80 mg/1TabletOralVGYAAN Pharmaceuticals LLC72664-213

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in